Personalized Cancer Medicine Market is Expected to Generate a Revenue of USD 707.1 Billion By 2033
As per the current market research conducted by the CMI Team, the global Personalized Cancer Medicine Market size is expected to record a CAGR of 8.2% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 347.8 Billion . By 2033, the valuation is anticipated to reach USD 707.1 Billion . Personalized Cancer Medicine Market : Growth Factors and Dynamics Advancements in Genomic Analysis : The advent of high-throughput sequencing technologies, such as next-generation sequencing (NGS), has revolutionized genomic analysis, allowing for comprehensive profiling of cancer genomes at an unprecedented scale and resolution. This has enabled the identification of specific genetic alterations driving cancer progression, thereby facilitating the development of targeted therapies. Rising Cancer Incidence : The global burden of cancer continues to increase, with a growing prevalence of various malignancies across differen...